Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Rotarix Liquid Vaccine in Healthy Infants
NCT00432380Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Primary completion
- Sep 2007
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rotavirus vaccine, live, oral in rotavirus infection (3 arms), sponsored by GSK. Primary endpoint: Number of Seroconverted Subjects for Anti-rotavirus (Anti-RV) Immunoglobulin A (IgA) Antibody at Month 3. Started Mar 2007; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00432380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432380.